Minsheng Securities released a research report on April 28 stating that it gave Bethany (300957.SZ) a recommended rating. The main reasons for the rating include: 1) 2023 revenue +10.14% year-on-year, and revenue growth from offline channels is steady; 2) gross margin decreased slightly and the cost structure is relatively stable; 3) focus on sensitive skin product development and multi-product strategy drive growth; 4) release of the 2023 equity distribution plan and the draft 2024 employee stock ownership plan. (Mainichi Keizai Shimbun)
民生证券4月28日发布研报称，给予贝泰妮（300957.SZ）推荐评级。评级理由主要包括：1）2023年营收同比+10.14%，线下渠道收入增长稳健；2）毛利率略有下降，成本结构较为稳定；3）专注敏感肌产品开发，多产品战略驱动成长；4）发布2023年度权益分配预案与2024年员工持股计划草案。（每日经济新闻）
Minsheng Securities released a research report on April 28 stating that it gave Bethany (300957.SZ) a recommended rating. The main reasons for the rating include: 1) 2023 revenue +10.14% year-on-year, and revenue growth from offline channels is steady; 2)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.